232 results
Page 3 of 12
S-8
ztm 3knvcrh
16 Mar 21
Registration of securities for employees
4:02pm
10-KT
bol5b 5ulqxppx
16 Mar 21
Annual report (with FYE transition)
2:24pm
8-K
EX-10.1
xznbehvrvfixrfne2
23 Feb 21
Company Continues to Execute Strategic Transformation Plan
4:15pm
8-K
EX-10.1
1o5w19a3i 6ys
7 Dec 20
Departure of Directors or Certain Officers
5:02pm
8-K
EX-99.2
kt0dhqezi0n5 zoqtc
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
8-K
EX-99.1
6dcqq
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
DEFA14A
6ikfrsp hoemku0
15 Oct 20
Additional proxy soliciting materials
7:20am
8-K
EX-3.1
ariucebbqdzo6a41s4y1
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
8-K
EX-99.1
fwrpa ryx
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
8-K
EX-10.1
v71 0mqbymqrjurcs
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
8-K
EX-10.2
fqz0q
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
S-8
EX-99.2
03y3vq3zk4zyh45jz3g
14 Aug 20
Registration of securities for employees
12:00am